Cargando…
Comments on ALLHAT and doxazosin
This commentary has two purposes: to summarize the rationale, design and initial results of the Antihypertensive and Lipid Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) trial; and to provide a history of the response to ALLHAT that led to a civil action and a Citizens Petition that was t...
Autor principal: | Krakoff, Lawrence R |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2001
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC64824/ https://www.ncbi.nlm.nih.gov/pubmed/11806807 http://dx.doi.org/10.1186/cvm-2-6-254 |
Ejemplares similares
-
Benefits and side effects of blood pressure lowering treatment: what was wrong with doxazosin in the ALLHAT?
por: Gavras, Irene, et al.
Publicado: (2001) -
Validation of Heart Failure Events in the Antihypertensive and Lipid Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) Participants Assigned to Doxazosin and Chlorthalidone
por: Piller, Linda B, et al.
Publicado: (2002) -
Hypothesis to explain poor outcomes in the ALLHAT and V-HeFT trials: decreased expression of heat shock proteins
por: Hooper, Philip L
Publicado: (2001) -
Impact of the ALLHAT Study Results on Managed Care
por: Anderson, Robert J.
Publicado: (2003) -
A new era in hypertension research: discussing the findings of ALLHAT
por: Furberg, Curt D
Publicado: (2001)